Practical Application of Immuno-Oncology in Renal Cell Carcinoma

Download All
In this online program based on a dynamic CCO symposium from the 2020 ASCO GU symposium, experts discuss the use of immunotherapy in treating patients with RCC. Use the updated irAE decision support tool and download the slides now.
Elizabeth R. Plimack, MD, MS
Program Director
Brian A. Costello, MD, MS
Elizabeth R. Plimack, MD, MS
Martin H. Voss, MD

Podcasts

Listen to Elizabeth R. Plimack, MD, MS; Brian A. Costello, MD; and Martin H. Voss, MD, discuss current best practices for first-line immunotherapy treatment of advanced renal cell carcinoma.

Elizabeth R. Plimack, MD, MS
Program Director
Brian A. Costello, MD, MS Martin H. Voss, MD
Released: August 31, 2020

Listen to Elizabeth R. Plimack, MD, MS; Brian A. Costello, MD; and Martin H. Voss, MD, discuss current best practices for treatment options in second-line and beyond for your patients with advanced renal cell carcinoma.

Brian A. Costello, MD, MS Elizabeth R. Plimack, MD, MS Martin H. Voss, MD Released: September 8, 2020

Listen to Elizabeth R. Plimack, MD, MS; Brian A. Costello, MD; and Martin H. Voss, MD, discuss clinical management pearls for IO-based therapy in patients with renal cell carcinoma.

Brian A. Costello, MD, MS Elizabeth R. Plimack, MD, MS Martin H. Voss, MD Released: September 21, 2020
Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

NCCN Logo
Supported by educational grants from
Eisai
Pfizer and EMD Serono

Supported by a medical education grant from
Exelixis, Inc.
Supported by an independent educational grant from
Merck & Co., Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings